Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Tuesday, November 24, 2020
Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH)
Final report confirms remdesivir benefits for COVID-19 | National Institutes of Health (NIH): The antiviral drug remdesivir shortened recovery time for patients hospitalized with COVID-19, based on results from the completed trial.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment